FIG. 7.
Suggested algorithm for planning NA discontinuation in HBeAg‐negative chronic hepatitis B. Of note, patients who show response to NA discontinuation should remain under surveillance for the development of hepatocellular carcinomas.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.